Help

Search Results

479 results

  1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 12

    Molecular mechanism involved in maleic hydrazide-mediated sucker control

    SHEN Y.; PAYAWULA R.; GOVINDURAJULU R.; KUDITHIPUDI C.; XU D.
    Altria Client Services LLC, Product Design & Maintenance, Richmond, VA, U.S.A.
    Molecular signals from the shoot apical meristem (SAM) mediate a hormonal signal that effectively inhibits axillary bud growth. Upon removal of the SAM, the hormonal signal is lost and enables axillary buds to grow into new shoots (or “suckers”) resulting ...
  2. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 35

    Genetic mapping and characterization of the pale yellow (Py) locus responsible for accelerated senescence in dark tobacco

    PRAMOD S.; ADAMS A.; DAVIS G.; LUSSO M.; FREDERICK J.; XU D.
    Altria Client Services LLC, Product Design & Maintenance, Richmond, VA, U.S.A.
    In commercial dark tobacco varieties (Nicotiana tabacum L.), accelerated senescence trait not only helps reduce TSNAs that are otherwise accumulated during the yellowing process associated with traditional dark varieties but also, could benefit growers in ...
  3. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 37

    Metabolic and transcriptomic shifts during tobacco leaf post-harvest senescence

    BOVET L.; HILFIKER A.; BATTEY J.; SIERRO N.; GOEPFERT S.
    PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland
    Tobacco is harvested after plant flowering, when the leaf senescence is more or less visible depending on cultivars. Before the drying phase, current practices allow the senescence to proceed until the detached leaf becomes yellow. This yellowing phase is ...
  4. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 49 (also presented at TSRC 2019)

    Nicotine variability of low nicotine cultivars versus normal nicotine cultivars

    LION K.; ADAMS A.; MORRIS W.; BROWN E.; IRVING B.; LUSSO M.; XU D.
    Altria Client Services LLC, Product Design & Maintenance, Richmond, VA, U.S.A.
    Nicotine is the most abundant alkaloid in cultivated tobacco (Nicotiana tabacum), typically constituting more than 90 % of total alkaloids. Recently, the U.S. Food and Drug Administration (FDA) issued an Advance Notice of Proposed Rulemaking (ANPRM) to ...
  5. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP 51

    Genetic and biochemical analysis of very low nicotine tobacco leaf

    KUDITHIPUDI C.(1); GOVINDARAJULU R.(2); BHUIYAN N.(2); SHEN Y.(1); XU D.(1)
    (1) Altria Client Services LLC, VA 23219, U.S.A.; (2) Eurofins Lancaster Laboratories, c/o Altria Client Services LLC, Richmond, VA, U.S.A.
    Recently, the U.S. Food and Drug Administration issued an advance notice of proposed rulemaking to obtain information for consideration in developing a tobacco product standard to set the maximum nicotine level in cigarette filler. Tobacco industry and ...
  6. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP Sustainability Forum

    Agro-Phyto Sustainability Forum

    WILDE L.(1); PRIBIC V.(2); EVANS W.(3); ROYO E.(4); BARGIACCHI E.(5); COLARD S.(6)
    (1) twentyfifty Ltd, Frome, U.K.; (2) JT International S.A., Geneva, Switzerland; (3) Imperial Tobacco Limited, Durban, South Africa; (4) Philip Morris International, Cape Town, South Africa; (5) Consortium INSTM, Firenze, Italy; (6) CORESTA, Paris, France
    In 2015, the United Nations published 17 sustainable development goals and their corresponding targets to be achieved by 2030. Like other sectors, the tobacco and alternative product sectors are likely to impact most of the goals. Consequently, it is ...
  7. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 02

    Comparative assessment of selected compounds yields in heated tobacco products

    JACCARD G.; TAFIN DJOKO D.; KORNELIOU A.; BELUSHKIN M.
    PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland
    A diverse range of heated tobacco products (HTPs) has been introduced in a growing number of markets by different manufacturers. They generally differentiate from cigarettes by the absence of combustion and a significant reduction in the levels of harmful ...
  8. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 03

    The effect of socio-economic inequalities: modelling of population health impact of introducing reduced-risk tobacco products into Germany

    RYTSAR R.(1); DJURDJEVIC S.(1); NUSSBAUM A.(2); KAUL A.(3,4); BENNEWITZ E.(3,4)
    (1) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (2) Philip Morris GmbH, Gräfelfing, Germany; (3) Saarland University, Department of Economics, Saarbrücken, Germany; (4) IPE Institute for Policy Evaluation, Frankfurt, Germany
    Education, income and occupation are the most commonly used descriptors of social inequalities in health. The socio-economic status (SES) of individuals (or groups of individuals) has proven to be important when describing and understanding smoking ...
  9. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 09

    The ABOUT™ Toolbox: toward the development of consumer-reported outcome measures that matter

    CHREA C.(1); SPIES E.(1); AFOLALU E.(1); BACSO A.(1); CLERC E.(1); MAINY N.(1); BINGGELI P.(1); WEITKUNAT R.(1); ACQUADRO C.(2); SALZBERGER T.(3); CANO S.(4); ABETZ-WEBB L.(5); ROSE J.(6)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) Mapi, an ICON plc Company, Lyon, France; (3) University of Economics and Business, Vienna, Austria; (4) ScaleReport, Ltd, Stotfold, U.K.; (5) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.; (6) Rose Research Center, Raleigh, U.S.A.
    Tobacco harm reduction promotes the substitution of reduced-risk products (RRPs) for cigarettes by adult smokers who would otherwise continue to smoke, while preventing RRP initiation among non-users. To operationalize this public health strategy, there ...
  10. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, ST 10

    Development of the ABOUT™–Health & Functioning: results from the preparatory phase

    SPIES E.(1); BACSO A.(1); CHREA C.(1); ABETZ-WEBB L.(2); AFOLALU E.(1); CLERC E.(1); WEITKUNAT R.(1)
    (1) PMI R&D, Philip Morris Products S.A., Neuchatel, Switzerland; (2) Patient-Centered Outcomes Assessments, Ltd, Macclesfield Cheshire, U.K.
    Switching cigarette smokers to significantly less harmful tobacco or nicotine products, or reduced-risk products (RRPs), has been recognized as a valuable and promising approach to reduce smoking-related population harm. Measuring self-reported experience ...